Moravcová, J <br/><br/>
Do transcriptionally silent BCR-ABL cells persist in CML patients in molecular remission after stem cell transplantation?  [electronic resource] 

 -  Leukemia  Jun 2001 
 - 997-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0887-6924 
<br/><br/><label>Standard No.: </label>10.1038/sj.leu.2402136  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cell Survival<br/>Chimera<br/>Female<br/>Follow-Up Studies<br/>Fusion Proteins, bcr-abl--biosynthesis<br/>Gene Expression Regulation, Leukemic<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--pathology<br/>Male<br/>Minisatellite Repeats<br/>Neoplastic Cells, Circulating<br/>Neoplastic Stem Cells--pathology<br/>RNA, Messenger--biosynthesis<br/>RNA, Neoplasm--biosynthesis<br/>Remission Induction<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Sensitivity and Specificity<br/>Transcription, Genetic